Sumant Ramachandra
Net worth: 173 300 $ as of 31/05/2026
Net worth: 173 300 $ as of 31/05/2026
Currently, Sumant Ramachandra is Senior VP, Chief Science & Technology Officer at Baxter International, Inc. Dr. Ramachandra is also on the board of Arog Pharmaceuticals, Inc. Dr. Ramachandra previously held the position of Chief Scientific Officer & SVP-Regulatory Affairs at Hospira, Inc., President-Research & Development at Synta Pharmaceuticals Corp., Senior Vice President, Head-Research & Development at Pfizer Essential Health and Vice President at Schering-Plough Corp. He received an undergraduate degree from Rutgers State University of New Jersey, a doctorate from the University of Medicine & Dentistry of New Jersey and an MBA from The Wharton School of the University of Pennsylvania.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 10/06/2026 | 10,000 ( 0.04% ) | 173 300 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Director/Board Member | 01/11/2024 |
Arog Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatments | Director/Board Member | - |
Lutris Pharma Ltd.
Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that improves anti cancer therapy effectiveness | Chief Executive Officer | 20/04/2025 |
| Companies | Position | End |
|---|---|---|
Immpact Bio USA, Inc.
Immpact Bio USA, Inc. BiotechnologyHealth Technology Develops cell therapy for treating cancer | Chief Executive Officer | 31/10/2024 |
| BAXTER INTERNATIONAL INC. | Chief Tech/Sci/R&D Officer | 01/12/2021 |
| HOSPIRA, INC. | Chief Tech/Sci/R&D Officer | 01/01/2015 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Chief Tech/Sci/R&D Officer | 05/05/2013 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Corporate Officer/Principal | 01/01/2008 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 12 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Hospira, Inc.
Hospira, Inc. Pharmaceuticals: MajorHealth Technology Provides drugs, IV sets and clinical integration & software, infusion pumps and implementation services | Health Technology |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Health Technology |
University of Medicine & Dentistry of New Jersey
University of Medicine & Dentistry of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arog Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatments | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer Essential Health
Pfizer Essential Health Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Lutris Pharma Ltd.
Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that improves anti cancer therapy effectiveness | Health Technology |
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
Immpact Bio USA, Inc.
Immpact Bio USA, Inc. BiotechnologyHealth Technology Develops cell therapy for treating cancer | Health Technology |
Select your edition
All financial news and data tailored to specific country editions